A device shall meet the general safety and performance requirements(GSPR) to comply MDR 2017/745.
MDD Essential
requirements(ER) are replaced by GSPRs.
MDR Annex I-GSPR have below
listed categories
- Chapter I:GENERAL REQUIREMENTS(1-9)
- Chapter II:REQUIREMENTS REGARDING DESIGN AND MANUFACTURE(10-22)
- Chapter III:REQUIREMENTS REGARDING THE INFORMATION SUPPLIED WITH THE DEVICE(23)
S.No |
Requirements |
MDD/ AIMDD Corresponding ERs |
Chapter I General Requirements |
||
GSPR 1 |
Performance and safety |
MDD and AIMDD ER 1 |
GSPR 2 |
Reduction of risks |
MDD ER 2 and AIMDD ER 8. |
GSPR 3 |
Risk management system |
NEW |
GSPR 4 |
Risk control
measures and residual risks |
ER 2 MDD and ER 6 AIMDD |
GSPR 5 |
Risks related to use |
MDD ER 1 and no
AIMDD ER |
GSPR 6 |
Device lifetime |
ER 4 MDD and ER 3 AIMDD |
GSPR 7 |
Packaging,
transport, storage |
ER 5 MDD and ER 4 AIMDD |
GSPR 8 |
Risk-benefit ratio |
MDD ER 6 and AIMDD ER 5 |
GSPR 9 |
Devices without a
medical purpose |
NEW |
Chapter
II-Requirements regarding design and manufacture |
||
GSPR 10 |
Chemical, physical
and biological properties |
MDD ER 7 and AIMDD ER 9 |
GSPR 10.1 |
General
considerations for materials |
ER 7.1 MDD and ER 9 AIMDD |
GSPR 10.2 |
Risks from
contaminants and residues |
ER 7.2 MDD and no
AIMDD ER |
GSPR 10.3 |
Compatibility with
materials and substances |
ER 7.3 MDD and no AIMDD ER |
GSPR 10.4 |
Substances |
NEW |
GSPR 10.4.1 |
Design and
manufacture of devices |
NEW |
GSPR 10.4.2 |
Justification
regarding the presence of CMR and/or endocrine-disrupting substances |
NEW |
GSPR 10.4.3 |
Guidelines on phthalates |
NEW |
GSPR 10.4.4 |
Guidelines on
other CMR and endocrine-disrupting substances |
NEW |
GSPR 10.4.5 |
Labelling |
NEW |
GSPR 10.5 |
Risk of
unintentional ingress |
ER 7.6 MDD and AIMDD ER 9 |
GSPR 10.6 |
Risks related to
particle size |
NEW |
GSPR 10.7 |
Infection and
microbial contamination |
MDD ER 8 and AIMDD ER 7 |
GSPR 11.0 |
Infection and
microbial contamination |
MDD ER 8 and AIMDD ER 7 |
GSPR 11.1 |
Risk of infection |
MDD ER 8.1 and no AIMDD ER |
GSPR 11.2 |
Design for reuse |
NEW |
GSPR 11.3 |
Devices with a
specific microbial state |
NEW |
GSPR 11.4 |
Devices delivered
sterile |
MDD ER 8.3 and AIMDD ER 7 |
GSPR 11.5 |
Validation for
sterile devices |
MDD ER 8.4 and no AIMDD ER |
GSPR 11.6 |
Environmental
controls |
MDD ER 8.5 and no AIMDD ER |
GSPR 11.7 |
Packaging for
non-sterile devices |
MDD ER 8.6 and no AIMDD ER |
GSPR 11.8 |
Labelling for
sterile state |
MDD ER 8.7 and no AIMDD ER |
GSPR 12 |
Devices incorporating
a medicinal product; substances
absorbed or locally dispersed |
MDD ER 7.4 and no AIMDD ER |
GSPR 12.1 |
Devices
incorporating a medicinal product |
MDD ER 7.4 and no AIMDD ER |
GSPR 12.2 |
Devices composed
of substances absorbed or locally dispersed |
NEW |
GSPR 13 |
Devices
incorporating materials of biological origin |
MDD ERs 7.4 and 8.2; and
no AIMDD ER |
GSPR 13.1 |
Tissues, cells or
derivatives of human origin |
MDD ER 7.4 and AIMDD ER 10 Scope extended |
GSPR 13.2 |
Tissues, cells or derivatives
of animal origin |
MDD ER 8.2 and no AIMDD ER |
GSPR 13.3 |
Other non-viable
biological substances |
NEW |
GSPR 14 |
Construction of
devices and interaction with their environment |
MDD ER 9 , ER 10.2 and AIMDD ER 9.1 |
GSPR 14.1 |
Use in combination |
MDD ER 9.1 and AIMDD ER 9.1 |
GSPR 14.2 |
Risks of interaction
with the environment |
14.2(a, b, f and g) -MDD ER 9.2. 14.2(c) -MDD ER 7.3. 14.2(e)- ER 7.6. 14.2 (d) -NEW Covered in AIMDD ER 8 |
GSPR 14.3 |
Risks of fire or
explosion |
MDD ER 9.3 and no AIMDD ER |
GSPR 14.4 |
Design for
adjustment, calibration and maintenance |
NEW |
GSPR 14.5 |
Design for
compatibility |
MDD ER 9.1 and AIMDD ER 9.1 |
GSPR 14.6 |
Measurement,
monitoring or display scales |
MDD ER 10.2 and no AIMDD ER |
GSPR 14.7 |
Design and manufacture
for safe disposal |
NEW |
GSPR 15 |
Devices with a
diagnostic or measuring function |
MDD ER 10.1 and 10.3 and no AIMDD ER |
GSPR 16 |
Protection against
radiation |
MDD ER 11 and AIMDD ER 8 |
GSPR 17 |
Electronic
programmable systems – devices that incorporate electronic programmable
systems and software that are devices in themselves |
17.1-MDD ER 12.1. and no AIMDD ER 17.2-MDD ER 12.1(a). and
AIMDD ER 9 17.3 & 17.4 - NEW |
GSPR 18 |
Active devices
and devices connected to them |
18.1-MDD ER 12.1 18.2-MDD ER 12.2 18.3-MDD ER 12.3 18.4-MDD ER 12.4 18.5-MDD ER 12.5 18.6-NEW 18.7-MDD ER 12.6 18.7-NEW |
GSPR 19 |
Particular
requirements for active implantable devices |
Covered in AIMDD |
GSPR 19.1 |
Particular risks to
be reduced for active implantable devices |
AIMDD ER 8 |
GSPR 19.2 |
Device compatibility
and reliability of energy |
AIMDD ER 9 |
GSPR 19.3 |
Identification of
devices and components |
AIMDD ER 11 |
GSPR 19.4 |
Identification code |
AIMDD ER 12 |
GSPR 20 |
Protection against
mechanical and thermal risks |
MDD ER 12.7 and no AIMDD ER |
GSPR 21 |
Protection against
the risks posed to the patient or user by devices supplying energy or
substances |
MDD ERs 12.8.1, 12.8.2 and 12.9 and AIMDD
ER 9 |
GSPR 22 |
Protection
against the risks posed by medical devices intended by the manufacturer for
use by lay persons |
NEW |
Click below link to know more about IVDR General Safety and Performance Requirements(Chapter I & II) :https://meddev-info.blogspot.com/2021/01/mdr-general-safety-and-performance.html
Source: REGULATION (EU) 2017/745 OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL of 5 April 2017 on medical devices, amending Directive 2001/83/EC, Regulation (EC) No 178/2002 and Regulation (EC) No 1223/2009 and repealing Council Directives 90/385/EEC and 93/42/EEC
No comments:
Post a Comment